The anthracycline metabolite doxorubicinol abolishes ryr2 sensitivity to physiological changes in luminal Ca21 through an interaction with calsequestrin

Citation

Hanna, A, Lam, A, Thekkedam, C et al. 2017, 'The anthracycline metabolite doxorubicinol abolishes ryr2 sensitivity to physiological changes in luminal Ca21 through an interaction with calsequestrin', Molecular Pharmacology, vol. 92, no. 5, pp. 576-587.

Year

2017

ANU Authors

Field of Research

  • Neurosciences Not Elsewhere Classified

Updated:  27 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers